Investors

Events and Presentations

Analyst Coverage

Corporate Governance

Publication Archive

Investor Contacts & Alerts

News Releases

Aug 7, 2018

Evofem Biosciences' Chief Medical Officer, Dr. Kelly Culwell, to Present at #BlogHer18 Creators Summit
Aug 2, 2018

Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Phase 3 Trial of Amphora for Hormone-free Contraception Continues to Move Ahead of Schedule; Top Line Data now expected in Late 2018
Jul 19, 2018

Evofem Biosciences to Report Second Quarter 2018 Results and Provide Corporate Update on August 2, 2018

-- Conference Call Scheduled for 11:00 a.m. EDT --
May 29, 2018

Evofem Biosciences to Present at Jefferies Global Healthcare Conference on June 7, 2018
May 24, 2018

Evofem Biosciences Announces Closing of Public Offering of Common Stock and Warrants

Show per page